시장보고서
상품코드
1110409

액체 충전 하드 캡슐 시장(사이즈별 : 대형 캡슐, 중형 캡슐, 소형 캡슐) : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2022-2031년)

Liquid Filled Hard Capsules Market (Size: Large Capsules, Medium Capsules, and Small Capsules) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 219 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 액체 충전 하드 캡슐(Liquid Filled Hard Capsules) 시장에 대해 분석했으며, 과거·현재 성장 동향과 시장 기회, 향후 시장 지표와 인사이트(2022-2031년), 시장 매출 동향(2017-2031년), 세계 시장의 CAGR 전망(2022-2031년) 등을 조사했습니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약 : 세계의 액체 충전 하드 캡슐 시장

제4장 시장 개요

  • 서론
    • 사이즈 정의
    • 업계 진화/발전
  • 개요
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회
  • 세계의 액체 충전 하드 캡슐 시장 분석과 예측(2017-2031년)
    • 시장 매출 예측(단위 : 100만 달러)
  • Porter's Five Forces 분석

제5장 주요 인사이트

  • 미국의 식이보충제 규제 개요
  • 식이보충제 규제 : 국가별
  • 비변성 II형 콜라겐 분석
  • 업계의 주요 이벤트
  • COVID-19 감염 확대의 업계에 대한 영향(밸류체인과 단기·중기·장기의 영향)

제6장 세계의 액체 충전 하드 캡슐 시장 : 사이즈별 분석과 예측

  • 서론과 정의
  • 주요 조사 결과/동향
  • 시장 규모 예측 : 사이즈별(금액·수량 기준, 2017-2031년)
    • 대형 캡슐
    • 중형 캡슐
    • 소형 캡슐
  • 시장 매력 분석 : 사이즈별

제7장 세계의 액체 충전 하드 캡슐 시장 : 용도별 분석과 예측

  • 서론과 정의
  • 주요 조사 결과/동향
  • 시장 규모 예측 : 용도별(금액·수량 기준, 2017-2031년)
    • 약물
    • 비타민·미네랄
    • 아미노산·펩티드·단백질
    • 지질
    • 기타
  • 시장 매력 분석 : 용도별

제8장 세계의 액체 충전 하드 캡슐 시장 : 최종사용자별 분석과 예측

  • 서론과 정의
  • 주요 조사 결과/동향
  • 시장 규모 예측 : 최종사용자별(금액·수량 기준, 2017-2031년)
    • 제약·바이오의약품 기업
    • 식이보충제 제조업체
    • 기타
  • 시장 매력 분석 : 최종사용자별

제9장 세계의 액체 충전 하드 캡슐 시장 : 지역별 분석과 예측

  • 주요 조사 결과
  • 시장 규모 예측 : 지역별
    • 북미
    • 유럽
    • 아시아
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장 매력 분석 : 지역별

제10장 북미의 액체 충전 하드 캡슐 시장 분석과 예측

  • 서론
    • 주요 조사 결과
  • 시장 규모 예측 : 사이즈별(금액·수량 기준, 2017-2031년)
  • 시장 규모 예측 : 용도별(금액·수량 기준, 2017-2031년)
  • 시장 규모 예측 : 최종사용자별(금액·수량 기준, 2017-2031년)
  • 시장 규모 예측 : 국가별(금액·수량 기준, 2017-2031년)
    • 미국
    • 캐나다
  • 시장 매력 분석

제11장 유럽의 액체 충전 하드 캡슐 시장 분석과 예측

제12장 아시아의 액체 충전 하드 캡슐 시장 분석과 예측

제13장 라틴아메리카의 액체 충전 하드 캡슐 시장 분석과 예측

제14장 중동 및 아프리카의 액체 충전 하드 캡슐 시장 분석과 예측

제15장 경쟁 상황

  • 시장 참여 기업 : 경쟁 매트릭스(계층별·기업 규모별)
  • 시장 점유율 분석 : 기업별(2021년)
  • 기업 개요
    • ACG
    • Altasciences
    • CapsCanada Corporation
    • Erawat Pharma Limited
    • Farmacapsulas SA
    • Fine USA Trading, Inc.
    • HealthCaps India Ltd.
    • Lefancaps
    • PLx Pharma, Inc.
    • Lonza Group
    • QUALICAPS
    • Roxlor
KSM 22.08.16

Liquid Filled Hard Capsules Market - Scope of Report

TMR's report on the global liquid filled hard capsules market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global liquid filled hard capsules market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global liquid filled hard capsules market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the liquid filled hard capsules market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global liquid filled hard capsules market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global liquid filled hard capsules market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global liquid filled hard capsules market.

The report delves into the competitive landscape of the global liquid filled hard capsules market. Key players operating in the global liquid filled hard capsules market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global liquid filled hard capsules market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market liquid filled hard capsules.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants' insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:

  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover's
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound
  • Primary Research
  • During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team's expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.
  • Data Triangulation: Information culled from "Secondary & Primary Sources" is cross-checked with "TMR Knowledge Repository", which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

  • Demographic Data: Healthcare expenditure, inflation rates, and others
  • Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
  • Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Liquid Filled Hard Capsules Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Size Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Liquid Filled Hard Capsules Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. U.S. Dietary Supplements Regulatory Overview
  • 5.2. Regulation of Dietary Supplements, by Country
  • 5.3. Un-denatured Type II Collagen Analysis
  • 5.4. Key Industry Events
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by Size

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value & Volume Forecast, by Size, 2017-2031
    • 6.3.1. Large Capsules
      • 6.3.1.1. Size 000
      • 6.3.1.2. Size 00 & 00E
    • 6.3.2. Medium Capsules
      • 6.3.2.1. Size 0 & 0E
      • 6.3.2.2. Size 1
      • 6.3.2.3. Size 2
    • 6.3.3. Small Capsules
      • 6.3.3.1. Size 3
      • 6.3.3.2. Size 4
      • 6.3.3.3. Size 5
  • 6.4. Market Attractiveness Analysis, by Size

7. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value & Volume Forecast, by Application, 2017-2031
    • 7.3.1. Drugs
    • 7.3.2. Vitamins & Mineral
    • 7.3.3. Amino Acids, Peptides, and Proteins
    • 7.3.4. Lipids
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value & Volume Forecast, by End-user, 2017-2031
    • 8.3.1. Pharmaceutical & Biopharmaceutical Companies
    • 8.3.2. Nutrition Supplement Manufacturers
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user/p>

9. Global Liquid Filled Hard Capsules Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value & Volume Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Liquid Filled Hard Capsules Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value & Volume Forecast, by Size, 2017-2031
    • 10.2.1. Large Capsules
      • 10.2.1.1. Size 000
      • 10.2.1.2. Size 00 & 00E
    • 10.2.2. Medium Capsules
      • 10.2.2.1. Size 0 & 0E
      • 10.2.2.2. Size 1
      • 10.2.2.3. Size 2
    • 10.2.3. Small Capsules
      • 10.2.3.1. Size 3
      • 10.2.3.2. Size 4
      • 10.2.3.3. Size 5
  • 10.3. Market Value & Volume Forecast, by Application, 2017-2031
    • 10.3.1. Drugs
    • 10.3.2. Vitamins & Mineral
    • 10.3.3. Amino Acids, Peptides, and Proteins
    • 10.3.4. Lipids
    • 10.3.5. Others
  • 10.4. Market Value & Volume Forecast, by End-user, 2017-2031
    • 10.4.1. Pharmaceutical & Biopharmaceutical Companies
    • 10.4.2. Nutrition Supplement Manufacturers
    • 10.4.3. Others
  • 10.5. Market Value & Volume Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. by Size
    • 10.6.2. by Application
    • 10.6.3. by End-user
    • 10.6.4. by Country

11. Europe Liquid Filled Hard Capsules Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value & Volume Forecast, by Size, 2017-2031
    • 11.2.1. Large Capsules
      • 11.2.1.1. Size 000
      • 11.2.1.2. Size 00 & 00E
    • 11.2.2. Medium Capsules
      • 11.2.2.1. Size 0 & 0E
      • 11.2.2.2. Size 1
      • 11.2.2.3. Size 2
    • 11.2.3. Small Capsules
      • 11.2.3.1. Size 3
      • 11.2.3.2. Size 4
      • 11.2.3.3. Size 5
  • 11.3. Market Value & Volume Forecast, by Application, 2017-2031
    • 11.3.1. Drugs
    • 11.3.2. Vitamins & Mineral
    • 11.3.3. Amino Acids, Peptides, and Proteins
    • 11.3.4. Lipids
    • 11.3.5. Others
  • 11.4. Market Value & Volume Forecast, by End-user, 2017-2031
    • 11.4.1. Pharmaceutical & Biopharmaceutical Companies
    • 11.4.2. Nutrition Supplement Manufacturers
    • 11.4.3. Others
  • 11.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. by Size
    • 11.6.2. by Application
    • 11.6.3. by End-user
    • 11.6.4. by Country/Sub-region

12. Asia Liquid Filled Hard Capsules Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value & Volume Forecast, by Size, 2017-2031
    • 12.2.1. Large Capsules
      • 12.2.1.1. Size 000
      • 12.2.1.2. Size 00 & 00E
    • 12.2.2. Medium Capsules
      • 12.2.2.1. Size 0 & 0E
      • 12.2.2.2. Size 1
      • 12.2.2.3. Size 2
    • 12.2.3. Small Capsules
      • 12.2.3.1. Size 3
      • 12.2.3.2. Size 4
      • 12.2.3.3. Size 5
  • 12.3. Market Value & Volume Forecast, by Application, 2017-2031
    • 12.3.1. Drugs
    • 12.3.2. Vitamins & Mineral
    • 12.3.3. Amino Acids, Peptides, and Proteins
    • 12.3.4. Lipids
    • 12.3.5. Others
  • 12.4. Market Value & Volume Forecast, by End-user, 2017-2031
    • 12.4.1. Pharmaceutical & Biopharmaceutical Companies
    • 12.4.2. Nutrition Supplement Manufacturers
    • 12.4.3. Others
  • 12.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. Japan
    • 12.5.2. China
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. by Size
    • 12.6.2. by Application
    • 12.6.3. by End-user
    • 12.6.4. by Country/Sub-region

13. Latin America Liquid Filled Hard Capsules Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value & Volume Forecast, by Size, 2017-2031
    • 13.2.1. Large Capsules
      • 13.2.1.1. Size 000
      • 13.2.1.2. Size 00 & 00E
    • 13.2.2. Medium Capsules
      • 13.2.2.1. Size 0 & 0E
      • 13.2.2.2. Size 1
      • 13.2.2.3. Size 2
    • 13.2.3. Small Capsules
      • 13.2.3.1. Size 3
      • 13.2.3.2. Size 4
      • 13.2.3.3. Size 5
  • 13.3. Market Value & Volume Forecast, by Application, 2017-2031
    • 13.3.1. Drugs
    • 13.3.2. Vitamins & Mineral
    • 13.3.3. Amino Acids, Peptides, and Proteins
    • 13.3.4. Lipids
    • 13.3.5. Others
  • 13.4. Market Value & Volume Forecast, by End-user, 2017-2031
    • 13.4.1. Pharmaceutical & Biopharmaceutical Companies
    • 13.4.2. Nutrition Supplement Manufacturers
    • 13.4.3. Others
  • 13.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. by Size
    • 13.6.2. by Application
    • 13.6.3. by End-user
    • 13.6.4. by Country/Sub-region

14. Middle East & Africa Liquid Filled Hard Capsules Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value & Volume Forecast, by Size, 2017-2031
    • 14.2.1. Large Capsules
      • 14.2.1.1. Size 000
      • 14.2.1.2. Size 00 & 00E
    • 14.2.2. Medium Capsules
      • 14.2.2.1. Size 0 & 0E
      • 14.2.2.2. Size 1
      • 14.2.2.3. Size 2
    • 14.2.3. Small Capsules
      • 14.2.3.1. Size 3
      • 14.2.3.2. Size 4
      • 14.2.3.3. Size 5
  • 14.3. Market Value & Volume Forecast, by Application, 2017-2031
    • 14.3.1. Drugs
    • 14.3.2. Vitamins & Mineral
    • 14.3.3. Amino Acids, Peptides, and Proteins
    • 14.3.4. Lipids
    • 14.3.5. Others
  • 14.4. Market Value & Volume Forecast, by End-user, 2017-2031
    • 14.4.1. Pharmaceutical & Biopharmaceutical Companies
    • 14.4.2. Nutrition Supplement Manufacturers
    • 14.4.3. Others
  • 14.5. Market Value & Volume Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. by Size
    • 14.6.2. by Application
    • 14.6.3. by End-user
    • 14.6.4. by Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. ACG
      • 15.3.1.1. Company Description
      • 15.3.1.2. Business Overview
      • 15.3.1.3. Strategic Overview
      • 15.3.1.4. SWOT Analysis
    • 15.3.2. Altasciences
      • 15.3.2.1. Company Description
      • 15.3.2.2. Business Overview
      • 15.3.2.3. Strategic Overview
      • 15.3.2.4. SWOT Analysis
    • 15.3.3. CapsCanada Corporation
      • 15.3.3.1. Company Description
      • 15.3.3.2. Business Overview
      • 15.3.3.3. Strategic Overview
      • 15.3.3.4. SWOT Analysis
    • 15.3.4. Erawat Pharma Limited
      • 15.3.4.1. Company Description
      • 15.3.4.2. Business Overview
      • 15.3.4.3. Strategic Overview
      • 15.3.4.4. SWOT Analysis
    • 15.3.5. Farmacapsulas S.A.
      • 15.3.5.1. Company Description
      • 15.3.5.2. Business Overview
      • 15.3.5.3. Strategic Overview
      • 15.3.5.4. SWOT Analysis
    • 15.3.6. Fine USA Trading, Inc.
      • 15.3.6.1. Company Description
      • 15.3.6.2. Business Overview
      • 15.3.6.3. Strategic Overview
      • 15.3.6.4. SWOT Analysis
    • 15.3.7. HealthCaps India Ltd.
      • 15.3.7.1. Company Description
      • 15.3.7.2. Business Overview
      • 15.3.7.3. Strategic Overview
      • 15.3.7.4. SWOT Analysis
    • 15.3.8. Lefancaps
      • 15.3.8.1. Company Description
      • 15.3.8.2. Business Overview
      • 15.3.8.3. Strategic Overview
      • 15.3.8.4. SWOT Analysis
    • 15.3.9. PLx Pharma, Inc.
      • 15.3.9.1. Company Description
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Business Overview
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5.SWOT Analysis
    • 15.3.10. Lonza Group
      • 15.3.10.1. Company Description
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Business Overview
      • 15.3.10.4. Strategic Overview
      • 15.3.10.5. SWOT Analysis
    • 15.3.11. QUALICAPS
      • 15.3.11.1. Company Description
      • 15.3.11.2. Business Overview
      • 15.3.11.3 .Strategic Overview
      • 15.3.11.3. SWOT Analysis
    • 15.3.12. Roxlor
      • 15.3.12.1. Company Description
      • 15.3.12.2. Business Overview
      • 15.3.12.3. Strategic Overview
      • 15.3.12.4. SWOT Analysis
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제